sb 203580 has been researched along with Glaucoma, Suspect in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calkins, DJ; Crish, SD; Dapper, JD; Pang, IH | 1 |
1 other study(ies) available for sb 203580 and Glaucoma, Suspect
Article | Year |
---|---|
Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy.
Topics: Activating Transcription Factor 2; Animals; Axons; Chaperonin 60; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Imidazoles; In Vitro Techniques; Intraocular Pressure; Mice; Nerve Tissue Proteins; Ocular Hypertension; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Retina; Retinal Degeneration; Retinal Ganglion Cells; Signal Transduction; Time Factors | 2013 |